Article: Trial for HIV prevention gel commences.

2004 NOV 16 - (NewsRx.com & NewsRx.net) -- Polydex Pharmaceuticals Limited (NASDAQ:POLXF) (BSE:PXL) announced the commencement of a phase III clinical trial of Ushercell (Cellulose Sulfate) a microbicidal gel that is being tested for its effectiveness in the prevention of HIV and other sexually transmitted infections.

In ongoing contraceptive studies, Cellulose Sulfate, a high molecular weight polymer, may also prove to be a major advance in fertility regulation. Preclinical and clinical studies have already demonstrated its high level of safety. Laboratory tests revealed the potential of Cellulose Sulfate to act as an effective guard against both unwanted ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!